123 related articles for article (PubMed ID: 7620835)
41. Alterations in angiotensin II receptor mediated signal transduction shortly after coronary artery constriction in the rat.
Huang H; Li P; Hamby CV; Reiss K; Meggs LG; Anversa P
Cardiovasc Res; 1994 Oct; 28(10):1564-73. PubMed ID: 8001047
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
[TBL] [Abstract][Full Text] [Related]
43. Type 1 angiotensin II receptors in rat and human sperm.
Vinson GP; Puddefoot JR; Ho MM; Barker S; Mehta J; Saridogan E; Djahanbakhch O
J Endocrinol; 1995 Feb; 144(2):369-78. PubMed ID: 7706989
[TBL] [Abstract][Full Text] [Related]
44. Effect of catecholamines on ornithine decarboxylase activity monitored in the perfused rat heart.
Guarnieri C; Muscari C; Flamigni F; Caldarera CR
Ital J Biochem; 1983; 32(2):77-83. PubMed ID: 6414988
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of insulin-like growth factor-I in hearts of rats with isoproterenol-induced cardiac hypertrophy.
Suzuki J; Ohno I; Nawata J; Miura S; Ikeda J; Shirato K
J Cardiovasc Pharmacol; 1999 Nov; 34(5):635-44. PubMed ID: 10547078
[TBL] [Abstract][Full Text] [Related]
46. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.
Shantz LM; Feith DJ; Pegg AE
Biochem J; 2001 Aug; 358(Pt 1):25-32. PubMed ID: 11485548
[TBL] [Abstract][Full Text] [Related]
47. Catecholamine-induced cardiac hypertrophy in a denervated, hemodynamically non-stressed heart transplant.
Larson DF; Copeland JG; Russell DH
Life Sci; 1985 Jul; 36(26):2477-89. PubMed ID: 3159947
[TBL] [Abstract][Full Text] [Related]
48. Insulin stimulation of ornithine decarboxylase activity in developing rat heart.
Webb PJ; Kimmel GL; Harmon JR; Sheehan DM; Delongchamp RR
J Pharmacol Exp Ther; 1986 Feb; 236(2):334-8. PubMed ID: 3511221
[TBL] [Abstract][Full Text] [Related]
49. Effects of the angiotensin II receptor antagonist losartan on herpes simplex virus-type 2 infection of cultured vero and cardiac neonatal myocytes.
Gardner PL; Mbuy GN; Knabb MT
Life Sci; 1994; 55(4):283-9. PubMed ID: 8028446
[TBL] [Abstract][Full Text] [Related]
50. Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat.
Grimm D; Holmer SR; Riegger GA; Kromer EP
Cardiovasc Pathol; 1999; 8(6):315-23. PubMed ID: 10615017
[TBL] [Abstract][Full Text] [Related]
51. Effect of captopril on isoproterenol-induced cardiac hypertrophy and polyamine contents.
Shimizu M; Sasaki H; Sanjo J; Ogawa K; Mizokami T; Yagi T; Kato H; Hamaya K; Namiki A; Isogai Y
Jpn Circ J; 1992 Nov; 56(11):1130-7. PubMed ID: 1453538
[TBL] [Abstract][Full Text] [Related]
52. Isoprenaline induced changes in ornithine decarboxylase activity and polyamine content in regions of the rat heart.
Tipnis UR; Frasier-Scott K; Skiera C
Cardiovasc Res; 1989 Jul; 23(7):611-9. PubMed ID: 2598215
[TBL] [Abstract][Full Text] [Related]
53. Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.
Farivar RS; Crawford DC; Chobanian AV; Brecher P
Hypertension; 1995 Apr; 25(4 Pt 2):809-13. PubMed ID: 7536716
[TBL] [Abstract][Full Text] [Related]
54. Role of sympathetic neurons in development of beta-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment.
Hou QC; Baker FE; Seidler FJ; Bartolome M; Bartolome J; Slotkin TA
J Dev Physiol; 1989 Mar; 11(3):139-46. PubMed ID: 2553794
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy.
Giordano E; Hillary RA; Vary TC; Pegg AE; Sumner AD; Caldarera CM; Zhang XQ; Song J; Wang J; Cheung JY; Shantz LM
Amino Acids; 2012 Feb; 42(2-3):507-518. PubMed ID: 21814794
[TBL] [Abstract][Full Text] [Related]
56. Central role for ornithine decarboxylase in beta-adrenoceptor mediated hypertrophy.
Schlüter KD; Frischkopf K; Flesch M; Rosenkranz S; Taimor G; Piper HM
Cardiovasc Res; 2000 Jan; 45(2):410-7. PubMed ID: 10728361
[TBL] [Abstract][Full Text] [Related]
57. Evidence that AMP-activated protein kinase can negatively modulate ornithine decarboxylase activity in cardiac myoblasts.
Passariello CL; Gottardi D; Cetrullo S; Zini M; Campana G; Tantini B; Pignatti C; Flamigni F; Guarnieri C; Caldarera CM; Stefanelli C
Biochim Biophys Acta; 2012 Apr; 1823(4):800-7. PubMed ID: 22230191
[TBL] [Abstract][Full Text] [Related]
58. Catecholamine-thyroid hormone interaction on myocardial ornithine decarboxylase.
Chideckel EW; Rosovski SJ; Belur EB
Am J Physiol; 1982 Oct; 243(4):E305-9. PubMed ID: 7124944
[TBL] [Abstract][Full Text] [Related]
59. Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat.
Schäfer M; Frischkopf K; Taimor G; Piper HM; Schlüter KD
Am J Physiol Cell Physiol; 2000 Aug; 279(2):C495-503. PubMed ID: 10913016
[TBL] [Abstract][Full Text] [Related]
60. beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo.
Copeland JG; Larson DF; Roeske WR; Russell DH; Womble JR
Br J Pharmacol; 1982 Mar; 75(3):479-83. PubMed ID: 6121595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
